Metformin: Ongoing Journey with Superdrug Revolution-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metformin: Ongoing Journey with Superdrug Revolution

Published:2019-02-21 Issue:1 Volume:9 Page:1-4
ISSN:2228-5881
Container-title:Advanced Pharmaceutical Bulletin
language:en
Short-container-title:Adv Pharm Bull

Author:

Ahmed EL-Arabey Amr¹^ORCID,Abdalla Mohnad²,Ali Eltayb Wafa³

Affiliation:

1. Pharmacology and Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Egypt.

2. Qingdao Institute of Bioenergy and Bioprocess Technology, Qingdao Shi, Shandong Sheng 266000, People’s Republic of China.

3. Faculty of Science and Technology, Shendi University, Shendi, Nher Anile, Sudan.

Abstract

Publisher

Maad Rayan Publishing Company

Subject

General Pharmacology, Toxicology and Pharmaceutics,Pharmaceutical Science

Reference8 articles.

1. New insight for metformin against bladder cancer

2. Update on off label use of metformin for obesity

3. Metformin and Autoimmunity: A “New Deal” of an Old Drug

4. Metformin as a geroprotector: experimental and clinical evidence

5. Effect of metformin on germ cell-specific apoptosis, oxidative stress and epididymal sperm quality after testicular torsion/detorsion in rats

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin dampens the progression of cholangiofibrosis induced by thioacetamide using deep learning;Heliyon;2024-09

2. Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review);International Journal of Molecular Medicine;2024-07-02

3. Metformin suppresses proliferation and glycolysis of gastric cancer by modulating ADAMTS12;Genes and Environment;2024-01-03

4. Metformin as a promising target for DPP4 expression: computational modeling and experimental validation;Medical Oncology;2023-08-25

5. The Risk of Age-Related Macular Degeneration Is Reduced in Type 2 Diabetes Patients Who Use Metformin;Pharmaceuticals;2023-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3